Schonfeld Strategic Advisors LLC Incyte Corp Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Incyte Corp stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 333,796 shares of INCY stock, worth $23.7 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

333,796

Previous 624,524 46.55%

Holding current value

$23.7 Million

Previous $37.9 Million 41.72%

% of portfolio

0.16%

Previous 0.26%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $16.7 Million - $19.9 Million	-290,728 Reduced 46.55%	333,796 $22.1 Million
Q2 2024 Aug 14, 2024	SELL	$51.18 - $63.75 $269,667 - $335,898	-5,269 Reduced 0.84%	624,524 $37.9 Million
Q1 2024 May 15, 2024	BUY	$56.55 - $66.59 $18.6 Million - $22 Million	329,789 Added 109.93%	629,793 $35.9 Million
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $14 Million - $17.3 Million	268,928 Added 865.39%	300,004 $18.8 Million
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $12.6 Million - $14.4 Million	-218,153 Reduced 87.53%	31,076 $1.8 Million
Q2 2023 Aug 14, 2023	BUY	$60.95 - $75.51 $15.2 Million - $18.8 Million	249,229 New	249,229 $15.5 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $1.01 Million - $1.27 Million	15,052 Added 171.67%	23,820 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $580,266 - $726,516	8,768 New	8,768 $585,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $304,758 - $383,043	-4,605 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $950,357 - $1.15 Million	-14,395 Reduced 75.76%	4,605 $366,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $446,103 - $521,956	-7,043 Reduced 27.04%	19,000 $1.4 Million
Q3 2021 Nov 16, 2021	BUY	$68.67 - $84.02 $1.79 Million - $2.19 Million	26,043 New	26,043 $1.79 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $2.31 Million - $2.8 Million	-28,651 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $2.44 Million - $3.14 Million	28,651 New	28,651 $3,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $503,162 - $738,872	-6,783 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.27 Million - $1.73 Million	-20,126 Reduced 74.79%	6,783 $497,000
Q4 2019 Feb 14, 2020	SELL	$73.04 - $95.72 $469,062 - $614,713	-6,422 Reduced 19.27%	26,909 $2.35 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $2.43 Million - $2.88 Million	33,331 New	33,331 $2.47 Million
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $736,155 - $888,153	-10,013 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $5.12 Million - $7.11 Million	-80,587 Reduced 88.95%	10,013 $861,000
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $2.86 Million - $3.42 Million	48,900 Added 117.27%	90,600 $5.76 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $2.57 Million - $3.1 Million	41,700 New	41,700 $2.88 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $1.72 Million - $2.37 Million	-28,220 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$83.06 - $100.98 $2.12 Million - $2.58 Million	25,550 Added 956.93%	28,220 $2.35 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $511,773 - $637,802	-5,470 Reduced 67.2%	2,670 $253,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $888,481 - $1.13 Million	8,140	8,140 $951,000

Others Institutions Holding INCY

# of Institutions

642

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.8B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Incyte Corp Transaction History